SlideShare a Scribd company logo
Use of Newer Noninvasive Pulse Wave Indices
  to detect and asses severity of Coronary Artery
                     Disease.


Gopi Krishna Rayidi M.D¹,Maddury Jyotsna MD, DM¹, Prof. D. Seshagiri rao MD,DM,
    Prof. O. Sai Satish MD, DM¹, Prof. Ramesh MD², Padmaja MD ².
¹ Department of Cardiology, ² Department of Clinical Pharmacology,
                   Nizam’s institute of medical sciences .hyderabad.
Pulse Wave Indices
MATERIALS AND METHODS
Inclusion criteria:
 51 patients who were undergoing coronary

  angiogram       either for the diagnosis or
  exclusion of CAD.
Exclusion criteria:
 Patients with:
        PVD.
        Valvular heart disease.
        CHF.
        Quality index of pulse <80%.
        Arrhythmias were excluded from the study.
AtCor Medical Applanation Tonometer Software Version 8,
 AtCor Medical, West Ryde, New South Wales, Australia
3 PATIENTS WERE EXCLUDED
   48 patients underwent coronary angiogram.
  CAD scoring based on severity
    Normal=0,
   <50 Stenosis =1
 Insignificant CAD (50-70% Stenosis in

           any CA except for LMCA < 50 )=2
   Significant CAD (>70% Stenosis in any CA)
  =3.
Total CAD severity score is calculated by the score
of each CA multiplied by no. of CA
involvement(Range 0-9).
 Sub scoring in significant CAD:
 70 to 80 = 3,
 80 to 90 = 4,
 > 90 =5,
 Each lesion score is multiplied by no Cor.Artery
involved.
So, Sub scoring in significant CAD -(Range 3-15).
NEWER PULSE WAVE INDICES

   Pressure Ischemia Index (PII - the product AI x SBP/
    SEVR)
   Viability Velocity Index (VVI = the product of SBP x
    PWV/ SEVR)
    Non Invasive CAD Severity Index (NI CAD SI =
    the product AI x SBP x PWV/ SEVR)



   Above indices Were used to detect CAD and severity
    of CAD
Baseline characteristics
AGE                        51.66±7.94
NO.OF PTS                  48
M:F                        29:19
DM                         24
HTN                        28
SMOKING                    13
F/H OF CAD                 14
PTS WITH NO RISK FACTORS   20
HR (MEAN±SD bpm )          74±11.61
SBP (MEAN±SD mm Hg)        129.85±16.45

DBP (MEAN±SD mm Hg)        79.27±4.94

PP (MEAN±SD mm Hg)         50.37±14.28
RESULTS
   Angiogram Score                    Pulse Wave Analysis


16 patients had                     CAD   NON           Significance
                                     GROUP CAD           (p≤0.05)
 angiographic score of 0                   GROUP
15 patients had S.V.D       NI     12389.4   5538.59    p≤0.005
13 patients had D.V.D.      CAD SI


04 patients had T.V.D.      VV      153911.4 127258.4   p≤0.018
                             Index
19 pts had severity score
 <5.                         PII     1526.1   748.29     p≤0.008

13pt had severity score>5
Discussion
   Central blood pressure and measures of arterial
    stiffness have been demonstrated to be important
    parameters in assessing CV risk.

    Central systolic pressure has been shown to be an
    independent predictor of incident CVD , independent
    of brachial systolic blood pressure.

   Previous studies used noninvasive parameters which
    can detect the presence or absence of CAD , but not
    the severity of CAD.
    Nurnberger et al,. found a strong positive correlation between
    Aix,pwv, and the risk of developing CAD, as assessed by the
    ESC Risk Score, in 144 asymptomatic patients without a
    previous history of CAD or atherosclerotic disease .

   Thomas Weber et al,study showed noninvasively determined
    manifestations of arterial stiffening and increased wave
    reflections are strong, independent risk markers for premature
    coronary artery disease on 465 pts, both of which were similar
    to the present study.


                                         1.J Hypertens. 2002;20: 2407–2414.
                                            2.Circulation. 2004;109:184-189
Limitations
   our study is the confinement to symptomatic patients
    referred for coronary angiography
   Our findings might not be applicable to the general
    population.
   Reasonable therapeutic strategy based on information
    obtained by PWA has to be tested in a randomized controlled
    trial.
    Radial artery AT has a sound physiologic
    basis and hence exciting potential in the arena
    of clinical medicine.
    published treatment and outcome data for it
    are less complete than for brachial blood
    pressure.
Conclusions
   Three New indices of Noninvasive Pulse Wave
    Analysis (NI CAD SI, VVI and PII) are excellent in
    the prediction of significant CAD.

   NI CAD SI is better in predicting even severity
    of C.A.D.
   Present study        findings might extend the
    recommendation for
            measuring arterial wall properties for the
             preventive management of CVD to a
             broader spectrum of the population.
            planning more aggressive diagnostic as
             well as therapeutic stratergies.
Thank You

More Related Content

What's hot

What's hot (20)

Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten Berg
Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten BergDual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten Berg
Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten Berg
 
Paciente con angina de esfuerzo y revascularización incompleta
Paciente con angina de esfuerzo y revascularización incompletaPaciente con angina de esfuerzo y revascularización incompleta
Paciente con angina de esfuerzo y revascularización incompleta
 
IFR - Instantenous wave free ratio
IFR - Instantenous wave free ratioIFR - Instantenous wave free ratio
IFR - Instantenous wave free ratio
 
AASK about Hypertension- JOURNAL CLUB
AASK  about Hypertension- JOURNAL CLUBAASK  about Hypertension- JOURNAL CLUB
AASK about Hypertension- JOURNAL CLUB
 
Clinical papers on TAVR
Clinical papers on TAVRClinical papers on TAVR
Clinical papers on TAVR
 
Antithrombotic therapy after pci in atrial fibrillation 2016
Antithrombotic therapy after pci in atrial fibrillation 2016Antithrombotic therapy after pci in atrial fibrillation 2016
Antithrombotic therapy after pci in atrial fibrillation 2016
 
Dual Antiplatelet Therapy for 12 or 30 months (DAPT Study)
Dual Antiplatelet Therapy for 12 or 30 months (DAPT Study)Dual Antiplatelet Therapy for 12 or 30 months (DAPT Study)
Dual Antiplatelet Therapy for 12 or 30 months (DAPT Study)
 
Valve disease in the Pandemic
Valve disease in the PandemicValve disease in the Pandemic
Valve disease in the Pandemic
 
Fundación EPIC _ Tratamiento anticoagulante/antiagregante al alta en TAVI
Fundación EPIC _ Tratamiento anticoagulante/antiagregante al alta en TAVIFundación EPIC _ Tratamiento anticoagulante/antiagregante al alta en TAVI
Fundación EPIC _ Tratamiento anticoagulante/antiagregante al alta en TAVI
 
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
 
ACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & ResultsACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & Results
 
Fundación EPIC _ Transient atrioventricular block after TAVI, what to do?
Fundación EPIC _ Transient atrioventricular block after TAVI, what to do?Fundación EPIC _ Transient atrioventricular block after TAVI, what to do?
Fundación EPIC _ Transient atrioventricular block after TAVI, what to do?
 
Abordaje terapéutico de la dislipemia en el paciente con enfermedad renal cró...
Abordaje terapéutico de la dislipemia en el paciente con enfermedad renal cró...Abordaje terapéutico de la dislipemia en el paciente con enfermedad renal cró...
Abordaje terapéutico de la dislipemia en el paciente con enfermedad renal cró...
 
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
 
04 FFR Johnson aimradial2017 - Hyperhemia
04 FFR Johnson aimradial2017 - Hyperhemia04 FFR Johnson aimradial2017 - Hyperhemia
04 FFR Johnson aimradial2017 - Hyperhemia
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
 
When to switch to antiplatelet monotherapy
When to switch to antiplatelet monotherapyWhen to switch to antiplatelet monotherapy
When to switch to antiplatelet monotherapy
 
Adressing Radial Artery Spasm
Adressing Radial Artery SpasmAdressing Radial Artery Spasm
Adressing Radial Artery Spasm
 
PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...
PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...
PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...
 
Tct surya dharma
Tct surya dharmaTct surya dharma
Tct surya dharma
 

Similar to How to present your reseach work in cardiology society of India.

EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...
EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...
EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...
EWMA
 
SMART transfers vs EDs AAN 2013. 3-8-13 FINAL
SMART transfers vs EDs AAN 2013. 3-8-13 FINALSMART transfers vs EDs AAN 2013. 3-8-13 FINAL
SMART transfers vs EDs AAN 2013. 3-8-13 FINAL
David Grosvenor
 
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Premier Publishers
 
Nguyen thuy ngan ta
Nguyen thuy ngan taNguyen thuy ngan ta
Nguyen thuy ngan ta
Duy Quang
 

Similar to How to present your reseach work in cardiology society of India. (20)

Pulse wave indice
Pulse wave indicePulse wave indice
Pulse wave indice
 
Risk scores in nste acs
Risk scores in nste acsRisk scores in nste acs
Risk scores in nste acs
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary Revascularization
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary Revascularization
 
How to Stratify Ischemic and Bleeding Risks in a Given Patient - Dr. Ariza
How to Stratify Ischemic and Bleeding Risks in a Given Patient - Dr. ArizaHow to Stratify Ischemic and Bleeding Risks in a Given Patient - Dr. Ariza
How to Stratify Ischemic and Bleeding Risks in a Given Patient - Dr. Ariza
 
12 aimradial2016 fri D Van Der Heijden
12 aimradial2016 fri D Van Der Heijden12 aimradial2016 fri D Van Der Heijden
12 aimradial2016 fri D Van Der Heijden
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
 
D-dimer.full
D-dimer.fullD-dimer.full
D-dimer.full
 
BCC4: Pierre Janin on Targets in Neuro-ICU
BCC4: Pierre Janin on Targets in Neuro-ICUBCC4: Pierre Janin on Targets in Neuro-ICU
BCC4: Pierre Janin on Targets in Neuro-ICU
 
Stroke related pneumonia _ APSR 2019 - Phuc Duc Dang
Stroke related pneumonia  _ APSR 2019 - Phuc Duc DangStroke related pneumonia  _ APSR 2019 - Phuc Duc Dang
Stroke related pneumonia _ APSR 2019 - Phuc Duc Dang
 
EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...
EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...
EWMA 2014 - EP452 DO ABI AND PULSE VOLUME COMPARE WITH THE DUPLEX SCAN FOR ID...
 
ROLE OF ANKLE BRACHIAL INDEX TO PREDICT PERIPHERAL ARTERIAL DISEASE, A STUDY ...
ROLE OF ANKLE BRACHIAL INDEX TO PREDICT PERIPHERAL ARTERIAL DISEASE, A STUDY ...ROLE OF ANKLE BRACHIAL INDEX TO PREDICT PERIPHERAL ARTERIAL DISEASE, A STUDY ...
ROLE OF ANKLE BRACHIAL INDEX TO PREDICT PERIPHERAL ARTERIAL DISEASE, A STUDY ...
 
Incremental predictive value of vascular assessments combined with the Framin...
Incremental predictive value of vascular assessments combined with the Framin...Incremental predictive value of vascular assessments combined with the Framin...
Incremental predictive value of vascular assessments combined with the Framin...
 
The American Journal of Cardiology
The American Journal of CardiologyThe American Journal of Cardiology
The American Journal of Cardiology
 
Calculating risk of ropture of an AAA- HSR 2014 congress
Calculating risk of ropture of an AAA- HSR 2014 congressCalculating risk of ropture of an AAA- HSR 2014 congress
Calculating risk of ropture of an AAA- HSR 2014 congress
 
What future trials do we need in CTOs?
What future trials do we need in CTOs?What future trials do we need in CTOs?
What future trials do we need in CTOs?
 
SMART transfers vs EDs AAN 2013. 3-8-13 FINAL
SMART transfers vs EDs AAN 2013. 3-8-13 FINALSMART transfers vs EDs AAN 2013. 3-8-13 FINAL
SMART transfers vs EDs AAN 2013. 3-8-13 FINAL
 
Dores et al
Dores et alDores et al
Dores et al
 
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
 
Nguyen thuy ngan ta
Nguyen thuy ngan taNguyen thuy ngan ta
Nguyen thuy ngan ta
 

More from Ramachandra Barik

Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
Ramachandra Barik
 

More from Ramachandra Barik (20)

Willens's syndrome.pptx
Willens's syndrome.pptxWillens's syndrome.pptx
Willens's syndrome.pptx
 
Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptx
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptx
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdf
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After Splenectomy
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
 
MISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptxMISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptx
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
 
Arrythmia-IV.pptx
Arrythmia-IV.pptxArrythmia-IV.pptx
Arrythmia-IV.pptx
 
Arrythmia-III.pptx
Arrythmia-III.pptxArrythmia-III.pptx
Arrythmia-III.pptx
 
Arrythmia-II.pptx
Arrythmia-II.pptxArrythmia-II.pptx
Arrythmia-II.pptx
 
Arrythmia-I.pptx
Arrythmia-I.pptxArrythmia-I.pptx
Arrythmia-I.pptx
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancy
 
Coronary guidewire
Coronary guidewireCoronary guidewire
Coronary guidewire
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomography
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human development
 
Intra aortic balloon pump
Intra aortic balloon pumpIntra aortic balloon pump
Intra aortic balloon pump
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendons
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
Avinash Rai
 

Recently uploaded (20)

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
 
Benefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational ResourcesBenefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational Resources
 
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
 
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfDanh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
 
Advances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdfAdvances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdf
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxMatatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptx
 
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
Operations Management - Book1.p  - Dr. Abdulfatah A. SalemOperations Management - Book1.p  - Dr. Abdulfatah A. Salem
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 

How to present your reseach work in cardiology society of India.

  • 1. Use of Newer Noninvasive Pulse Wave Indices to detect and asses severity of Coronary Artery Disease. Gopi Krishna Rayidi M.D¹,Maddury Jyotsna MD, DM¹, Prof. D. Seshagiri rao MD,DM, Prof. O. Sai Satish MD, DM¹, Prof. Ramesh MD², Padmaja MD ². ¹ Department of Cardiology, ² Department of Clinical Pharmacology, Nizam’s institute of medical sciences .hyderabad.
  • 3. MATERIALS AND METHODS Inclusion criteria:  51 patients who were undergoing coronary angiogram either for the diagnosis or exclusion of CAD. Exclusion criteria:  Patients with:  PVD.  Valvular heart disease.  CHF.  Quality index of pulse <80%.  Arrhythmias were excluded from the study.
  • 4. AtCor Medical Applanation Tonometer Software Version 8, AtCor Medical, West Ryde, New South Wales, Australia
  • 5. 3 PATIENTS WERE EXCLUDED 48 patients underwent coronary angiogram. CAD scoring based on severity Normal=0, <50 Stenosis =1  Insignificant CAD (50-70% Stenosis in any CA except for LMCA < 50 )=2 Significant CAD (>70% Stenosis in any CA) =3.
  • 6. Total CAD severity score is calculated by the score of each CA multiplied by no. of CA involvement(Range 0-9). Sub scoring in significant CAD: 70 to 80 = 3, 80 to 90 = 4, > 90 =5, Each lesion score is multiplied by no Cor.Artery involved. So, Sub scoring in significant CAD -(Range 3-15).
  • 7. NEWER PULSE WAVE INDICES  Pressure Ischemia Index (PII - the product AI x SBP/ SEVR)  Viability Velocity Index (VVI = the product of SBP x PWV/ SEVR)  Non Invasive CAD Severity Index (NI CAD SI = the product AI x SBP x PWV/ SEVR)  Above indices Were used to detect CAD and severity of CAD
  • 8. Baseline characteristics AGE 51.66±7.94 NO.OF PTS 48 M:F 29:19 DM 24 HTN 28 SMOKING 13 F/H OF CAD 14 PTS WITH NO RISK FACTORS 20 HR (MEAN±SD bpm ) 74±11.61 SBP (MEAN±SD mm Hg) 129.85±16.45 DBP (MEAN±SD mm Hg) 79.27±4.94 PP (MEAN±SD mm Hg) 50.37±14.28
  • 9. RESULTS Angiogram Score Pulse Wave Analysis 16 patients had CAD NON Significance GROUP CAD (p≤0.05) angiographic score of 0 GROUP 15 patients had S.V.D NI 12389.4 5538.59 p≤0.005 13 patients had D.V.D. CAD SI 04 patients had T.V.D. VV 153911.4 127258.4 p≤0.018 Index 19 pts had severity score <5. PII 1526.1 748.29 p≤0.008 13pt had severity score>5
  • 10.
  • 11. Discussion  Central blood pressure and measures of arterial stiffness have been demonstrated to be important parameters in assessing CV risk.  Central systolic pressure has been shown to be an independent predictor of incident CVD , independent of brachial systolic blood pressure.  Previous studies used noninvasive parameters which can detect the presence or absence of CAD , but not the severity of CAD.
  • 12. Nurnberger et al,. found a strong positive correlation between Aix,pwv, and the risk of developing CAD, as assessed by the ESC Risk Score, in 144 asymptomatic patients without a previous history of CAD or atherosclerotic disease .  Thomas Weber et al,study showed noninvasively determined manifestations of arterial stiffening and increased wave reflections are strong, independent risk markers for premature coronary artery disease on 465 pts, both of which were similar to the present study. 1.J Hypertens. 2002;20: 2407–2414. 2.Circulation. 2004;109:184-189
  • 13. Limitations  our study is the confinement to symptomatic patients referred for coronary angiography  Our findings might not be applicable to the general population.  Reasonable therapeutic strategy based on information obtained by PWA has to be tested in a randomized controlled trial.
  • 14. Radial artery AT has a sound physiologic basis and hence exciting potential in the arena of clinical medicine.  published treatment and outcome data for it are less complete than for brachial blood pressure.
  • 15. Conclusions  Three New indices of Noninvasive Pulse Wave Analysis (NI CAD SI, VVI and PII) are excellent in the prediction of significant CAD.  NI CAD SI is better in predicting even severity of C.A.D.  Present study findings might extend the recommendation for  measuring arterial wall properties for the preventive management of CVD to a broader spectrum of the population.  planning more aggressive diagnostic as well as therapeutic stratergies.